Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine
Open Access
- 1 December 2017
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 35 (49), 6879-6884
- https://doi.org/10.1016/j.vaccine.2017.09.032
Abstract
No abstract availableFunding Information
- Sanofi Pasteur
- GlaxoSmithKline
- MedImmune
- Merck & Co.
- Novartis
- Pfizer
- Protein Sciences
This publication has 9 references indexed in Scilit:
- Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-OldsPEDIATRICS, 2017
- Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trialThe Lancet Infectious Diseases, 2016
- Red Book (2015)Published by American Academy of Pediatrics (AAP) ,2015
- Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting SystemAmerican Journal of Obstetrics and Gynecology, 2013
- No risk of Guillain–Barré syndrome found after meningococcal conjugate vaccination in two large cohort studiesPharmacoepidemiology and Drug Safety, 2012
- Risk of Guillain–Barré syndrome after meningococcal conjugate vaccinationPharmacoepidemiology and Drug Safety, 2012
- Infectious MononucleosisThe New England Journal of Medicine, 2010
- Epidemiology of youth suicide and suicidal behaviorCurrent Opinion in Pediatrics, 2009
- Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse EventsMedical Care, 2007